Stacey Pugh

Stacey Pugh is a seasoned medical technology executive with more than 20 years of experience spanning clinical research, product development, and global commercialization. Her career traces an uncommon arc—from critical care nursing to chief executive—giving her a rare combination of patient-centered insight and operational command across five medtech companies, seventy-plus products.
She currently serves as Chief Executive Officer of Endogenex, a clinical-stage medical device company based in Minneapolis, Minnesota, that is developing a first-of-its-kind endoscopic therapy for type 2 diabetes and metabolic disease. Appointed CEO in March 2023, Stacey leads the company through its pivotal clinical program and the continued development of the Endogenex System—an outpatient, non-thermal pulsed electric field therapy designed to regenerate the duodenal mucosa and submucosa and restore healthy metabolic signaling in patients with T2D.